chr2-219172872-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015680.6(CNPPD1):c.947T>A(p.Leu316Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000693 in 1,443,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015680.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CNPPD1 | NM_015680.6 | c.947T>A | p.Leu316Gln | missense_variant | 8/8 | ENST00000360507.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CNPPD1 | ENST00000360507.10 | c.947T>A | p.Leu316Gln | missense_variant | 8/8 | 1 | NM_015680.6 | P1 | |
CNPPD1 | ENST00000409789.5 | c.947T>A | p.Leu316Gln | missense_variant | 9/9 | 1 | P1 | ||
CNPPD1 | ENST00000453038.5 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000847 AC: 2AN: 236256Hom.: 0 AF XY: 0.00000787 AC XY: 1AN XY: 127038
GnomAD4 exome AF: 6.93e-7 AC: 1AN: 1443810Hom.: 0 Cov.: 60 AF XY: 0.00000140 AC XY: 1AN XY: 716134
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.947T>A (p.L316Q) alteration is located in exon 8 (coding exon 8) of the CNPPD1 gene. This alteration results from a T to A substitution at nucleotide position 947, causing the leucine (L) at amino acid position 316 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at